Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
776 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-08-28)
Due Date
August 28, 2027
Grace Period Ends
February 28, 2028
Application History
50 eventsDate | Code | Type | Description |
---|---|---|---|
Feb 11, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
May 1, 2020 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Feb 27, 2019 | INNA | R | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
Feb 19, 2019 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
Aug 17, 2018 | INNP | P | PARTIAL INVALIDATION PROCESSED BY THE IB |
Jun 19, 2018 | INPC | P | INVALIDATION PROCESSED |
Jun 19, 2018 | INPS | P | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
Jun 19, 2018 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
May 11, 2018 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
Sep 11, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Sep 11, 2017 | 71AG | O | REGISTERED-SEC.71 ACCEPTED |
Sep 11, 2017 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
Aug 14, 2017 | ES71 | I | TEAS SECTION 71 RECEIVED |
Aug 28, 2016 | REM4 | E | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
Mar 3, 2016 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Mar 3, 2016 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Nov 26, 2015 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED |
Jun 20, 2015 | INNP | P | PARTIAL INVALIDATION PROCESSED BY THE IB |
May 15, 2015 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
May 4, 2015 | XXCR | P | GENERIC MADRID TRANSACTION CREATED |
May 4, 2015 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB |
Mar 12, 2015 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Nov 30, 2014 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
Nov 17, 2014 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Mar 30, 2014 | 71AG | O | REGISTERED-SEC.71 ACCEPTED |
Mar 30, 2014 | 71AF | I | REGISTERED-SEC.71 FILED |
Mar 30, 2014 | 71.P | O | REGISTERED - PARTIAL SEC 71 ACCEPTED |
Mar 30, 2014 | 15AK | O | REGISTERED - SEC. 15 ACKNOWLEDGED |
Mar 30, 2014 | NA15 | E | SEC. 15 ACKNOWLEDGEMENT - E-MAILED |
Mar 30, 2014 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
Mar 30, 2014 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
Mar 21, 2014 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Feb 27, 2014 | E15R | I | TEAS SECTION 15 RECEIVED |
Feb 27, 2014 | ES71 | I | TEAS SECTION 71 RECEIVED |
Feb 27, 2014 | 15AF | I | REGISTERED - SEC. 15 AFFIDAVIT FILED |
May 24, 2013 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Jan 28, 2011 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Dec 24, 2009 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Mar 26, 2009 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Dec 26, 2008 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Dec 13, 2007 | FIMP | P | FINAL DISPOSITION PROCESSED |
Dec 13, 2007 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Dec 5, 2007 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Aug 28, 2007 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jun 12, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jun 1, 2007 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
May 23, 2007 | NPUB | O | NOTICE OF PUBLICATION |
May 17, 2007 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
May 17, 2007 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Apr 13, 2007 | ALIE | A | ASSIGNED TO LIE |
Detailed Classifications
Class 001
Reagents for chemical laboratory analysis and science, not for medical or veterinary purposes, in particular for analysis of environment and food products;[ chemically coated non-medical test-strips;] testing kits containing analysis reagents and receptacles all for laboratory and research use in the nature of biochemical and immunological investigations not for medical or veterinary purposes
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
[ Pharmaceutical preparations used in the detection, monitoring, diagnosis, prevention and treatment of infectious diseases; ] in-vitro-diagnostic reagents and preparations for medical purposes, namely, in-vitro detection, monitoring, diagnosis of infectious diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
USPTO Documents
Loading USPTO documents...